Type-specific screening for asymptomatic herpes infection in pregnancy: A decision analysis

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 6, 2005, Pages 731-736

  Cleary, Kirsten Lawrence ^a,b   Paré, Emmanuelle ^a   Stamilio, David ^a   Macones, George A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

CESAREAN SECTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MATERNAL CARE; NEWBORN; NEWBORN DEATH; NEWBORN INFECTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; CESAREAN SECTION; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RECURRENCE; SENSITIVITY AND SPECIFICITY; VIRUS SHEDDING;

EID: 20744432479     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00540.x     Document Type: Review

References (21)

1. Sheffield J, Hollier L, Hill J, Stuart G, Wendel G. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003;102:1396-1403.
2. Brown Z, Wald A, Morrow R, Selke S, Zeh J, Corey L. Effect of serologic status and caesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-209.
3. Fleming D, McQuillan G, Johnson R. Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med 1997;337:1105-1111.
4. Kulhanjian J, Soroush B, Au D, et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992;326:916-920.
5. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. J Clin Invest 1997;99:1097.
6. Boggess K, Watts H, Hobson A, Ashley R, Brown Z, Corey L. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy. Am J Obstet Gynecol 1997;176:443-451.
7. Hensleigh P, Andrews A, Brown Z, Greenspoon J, Yasukawa L, Prober C. Genital herpes during pregnancy: inability to distinguish primary and recurrent infections clinically. Obstet Gynecol 1997;89:891-895.
8. Frenkel L, Garratty E, Shen J, Wheeler N, Clark O, Bryson Y. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993;118:414-418.
9. Lafferty W, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181:1454-1457.
10. Benedetti J. Recurrence rates in genital herpes after symptomatic first episode infection. Ann Intern Med 1994;121:847-854.
11. Corey L, Adams H, Brown Z, Holmes K. Genital herpes simplex virus infections: clinical manifestations, course and complications. Ann Intern Med 1983;98:958-972.
12. Reeves W. Risk of recurrence after first episodes of genital herpes; relation to HSV type and antibody response. N Engl J Med 1981;305:315.
13. Goldberg L, Kaufman R, Kurtz T, et al. Long-term suppression of recurrent genital herpes with acyclovir. Arch Dermatol 1993;129:582-587.
14. Frenkel L, Brown Z, Bryson Y, et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1990;164:569-576.
15. Cunningham A, Lee F, Ho D, et al. Herpes simplex virus type 2 antibody in patients attending antenatal of STD clinics. Med J Aust 1993;158:525-528.
16. Benedetti J, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infections decreases in frequency over time. Ann Intern Med 1999;131:14-20.
17. Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991;324:444-449.
18. Rouse D, Stringer J. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol 2000;183:400-406.
19. Brown Z, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-515.
20. Menacker F, Curtin S. Trends in cesarean birth and vaginal birth after previous cesarean, 1991-99. Natl Vital Stat Rep 2003;49:1-15.
21. Ashley R. Sorting out the new HSV type specific antibody tests. Sex Transm Dis 2001;77:232-237.